Influenza Diagnostic Market To Reach $3.3 Billion By 2024: Grand View Research, Inc.
The influenza diagnostics market is expected to reach USD 3.3
billion by 2024, according to a new report by Grand View Research, Inc.
Influenza, or "the flu," is an infectious disease and affects the
upper respiratory tract in humans. The disease is common in children and
elderly population (aged 65 years and above). The disease has a huge impact on
public health. Influenza A virus poses a greater risk as compared to the
influenza B virus. The B virus is responsible for 20% to 25% of infections
globally. The growth in the influenza diagnostic market is attributed to
factors such as emergence of technologically advanced diagnostic tests with
shorter turnaround time; initiatives by regulatory bodies, such as CDC’s
seasonal influenza vaccination for prevention and control of seasonal influenza;
and the demand created for influenza diagnosis in the flu season.
Rapid Influenza Diagnostic Tests
(RIDTs) accounted for the largest share in 2015. RIDTs are tests that deliver
accurate results in approximately 15 minutes. This factor deems them efficient,
which has resulted in the lucrative growth of this segment with the fastest
CAGR. Reverse transcription polymerase chain reaction (RT-PCR) holds the second
highest market share following RIDTs, and this can be attributed to the fact
that it provides detailed analytical results, sharper turnaround times, and
high throughput.
Hospitals held the highest market
share in 2015, but Point-of-Care Testing (POCT) is anticipated to overtake and
lead the market in the coming future, owing to the increasing usage of POCT
because of its ease of use and short turnaround times.
North America dominates the
market, due to a high focus of the government and healthcare bodies to control
influenza.
Browse full research report on Influenza Diagnostic
Market: http://www.grandviewresearch.com/industry-analysis/influenza-diagnostics-market
Further Key Findings From the Study Suggest:
- North America is anticipated to dominate the global
influenza diagnostics market. The high adoption rates of in vitro
diagnostics and presence of technologically advanced medical devices is
expected to drive growth in the region.
- The Asia Pacific region is anticipated to be the
fastest growing region in the study period. This growth is attributed to
factors such as increasing initiatives by the countries to counter the
incidence of the disease. For instance, CDC reached a cooperative
agreement with South-East Asian Region to fund non research-related
bilateral influenza as a measure to respond to avian, seasonal, and
pandemic influenza.
- The RIDT segment is expected to grow at a significant
rate compared to others and accounts for the largest share in 2015.
- This market comprises several local as well as global
players. Some of the major players of this vertical include Becton,
Dickinson and Company, Roche Diagnostics, Alere, Quidel Corporation, and
Thermo Fisher Scientific.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented the influenza diagnostics
market on the basis of test type, end use, and region:
Test Type Outlook (Revenue, USD Million, 2013
- 2024)
- RIDTs
- RT-PCR
- Cell
Culture
- Others
End-use Outlook (Revenue, USD Million, 2013 - 2024)
- Hospital
- Point-of-Care
Testing
- Laboratories
Regional Outlook (Revenue, USD Million, 2013 - 2024)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- China
- India
- Latin
America
- Brazil
- Mexico
- MEA
- South
Africa
- Saudi
Arabia
Access Press Release
By Grand View Research: http://www.grandviewresearch.com/press-release/global-influenza-diagnostics-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
Comments
Post a Comment